Often there are no or few symptoms. Occasionally there may be tiredness or pain in the upper right side of the abdomen. Complications<unk><unk>  can develop into a fibrosis or a<unk>  cancer. For people affected by NAFLD, the 10-year survival rate was about 80%. The rate of progression of fibrosis is estimated to be one per 7 years in NASH and one per 14 years in NAFLD, with an increasing speed. There is a strong relationship between these pathologies and metabolic illnesses (diabetes type II, metabolic syndrome). These pathologies can also affect non-obese people, who are then at a higher risk. Less than 10% of people with cirrhotic alcoholic<unk>  will develop hepatocellular carcinoma, the most common type of primary<unk>  cancer in adults, but up to 45% people with NASH without cirrhosis can develop hepatocellular carcinoma. The condition is also associated with other diseases that influence fat metabolism.
Fatty liver disease
Wilson's disease
Alcoholic liver disease
Viral hepatitis
Alcoholic hepatitis
Primary sclerosing cholangitis
Non-alcoholic fatty liver disease
Autoimmune hepatitis